Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

ABO blood group and risk of cancer: A register-based cohort study of 1.6 million blood donors

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Trends in thyroid cancer: Retrospective analysis of incidence and survival in Denmark 1980-2014

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Anaplastic thyroid carcinoma in Denmark 1996-2012: A national prospective study of 219 patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. The Validity of Daily Self-Assessed Perceived Stress Measured Using Smartphones in Healthy Individuals: Cohort Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Prevalence of anti-Hepatitis E virus immunoglobulin G in HIV-infected individuals over three decades

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Association of Blood Donor Sex and Prior Pregnancy With Mortality Among Red Blood Cell Transfusion Recipients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Senthil K Vasan
  • Jinseub Hwang
  • Klaus Rostgaard
  • Olof Nyrén
  • Henrik Ullum
  • Ole B V Pedersen
  • Christian Erikstrup
  • Mads Melbye
  • Henrik Hjalgrim
  • Yudi Pawitan
  • Gustaf Edgren
Vis graf over relationer

INTRODUCTION: The associations between ABO blood group and cancer risk have been studied repeatedly, but results have been variable. Consistent associations have only been reported for pancreatic and gastric cancers.

MATERIALS AND METHODS: We estimated associations between different ABO blood groups and site-specific cancer risk in a large cohort of healthy blood donors from Sweden and Denmark.

RESULTS: A total of 1.6 million donors were followed over 27 million person-years (20 million in Sweden and 7 million in Denmark). We observed 119,584 cancer cases. Blood groups A, AB and B were associated either with increased or decreased risk of cancer at 13 anatomical sites (p≤0.05), compared to blood group O. Consistent with assessment using a false discovery rate approach, significant associations with ABO blood group were observed for cancer of the pancreas, breast, and upper gastrointestinal tract (mouth, salivary glands, pharynx, esophageal adenocarcinoma and stomach).

DISCUSSION: Our study reconfirms the association between ABO blood group and cancer risk and exact underlying mechanisms involved needs further research.

OriginalsprogEngelsk
TidsskriftCancer epidemiology
Vol/bind44
Sider (fra-til)40-43
Antal sider4
ISSN1877-7821
DOI
StatusUdgivet - okt. 2016

ID: 49163190